Expert meeting on neuroblastoma

We are extremely proud to have supported and sponsored an expert meeting where the main topic was the treatment of high-risk neuroblastoma. Domestic and international experts were presented with the latest research in this field and previous experiences were shared to improve the future application of therapy for this rare disease. We gathered all parties dealing with neuroblastoma in one place to socialise and share knowledge with the aim to further improve the treatment of patients in Serbia. Neuroblastoma is the leading cancer‐related cause of death in children, and the targeted cancer immunotherapy we distribute reflects our commitment to work towards equity in social opportunity, healthcare, and access to diagnosis and therapies for people living with a rare disease.